169 related articles for article (PubMed ID: 9172002)
1. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
[TBL] [Abstract][Full Text] [Related]
3. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
[TBL] [Abstract][Full Text] [Related]
4. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
[TBL] [Abstract][Full Text] [Related]
5. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
6. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
8. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
[TBL] [Abstract][Full Text] [Related]
9. Proximity of TPR and NTRK1 rearranging loci in human thyrocytes.
Roccato E; Bressan P; Sabatella G; Rumio C; Vizzotto L; Pierotti MA; Greco A
Cancer Res; 2005 Apr; 65(7):2572-6. PubMed ID: 15805251
[TBL] [Abstract][Full Text] [Related]
10. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
Greco A; Fusetti L; Miranda C; Villa R; Zanotti S; Pagliardini S; Pierotti MA
Oncogene; 1998 Feb; 16(6):809-16. PubMed ID: 9488046
[TBL] [Abstract][Full Text] [Related]
11. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic rearrangements of the NTRK1/NGF receptor.
Pierotti MA; Greco A
Cancer Lett; 2006 Jan; 232(1):90-8. PubMed ID: 16242838
[TBL] [Abstract][Full Text] [Related]
13. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
Greco A; Miranda C; Pierotti MA
Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization of the human NTRK1 gene.
Greco A; Villa R; Pierotti MA
Oncogene; 1996 Dec; 13(11):2463-6. PubMed ID: 8957089
[TBL] [Abstract][Full Text] [Related]
15. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma.
Brzeziańska E; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Jun; 28(3):221-9. PubMed ID: 17627253
[TBL] [Abstract][Full Text] [Related]
16. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
Greco A; Orlandi R; Mariani C; Miranda C; Borrello MG; Cattaneo A; Pagliardini S; Pierotti MA
Cell Growth Differ; 1993 Jul; 4(7):539-46. PubMed ID: 8398895
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.
Valent A; Danglot G; Bernheim A
Eur J Hum Genet; 1997; 5(2):102-4. PubMed ID: 9195161
[TBL] [Abstract][Full Text] [Related]
19. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan.
Kitamura Y; Minobe K; Nakata T; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Onda M; Emi M
J Hum Genet; 1999; 44(2):96-102. PubMed ID: 10083732
[TBL] [Abstract][Full Text] [Related]
20. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
Roccato E; Pagliardini S; Cleris L; Canevari S; Formelli F; Pierotti MA; Greco A
Oncogene; 2003 Feb; 22(6):807-18. PubMed ID: 12584559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
